Now livetag icon
Ad Intelligence Presents: Ads in ChatGPT & Google. Download the reportbanner icon

ACC Guideline Clinical App のアプリ分析 5月3日

ACC Guideline Clinical App

ACC Guideline Clinical App

  • American College of Cardiology Foundation
  • Google Play ストア
  • 無料
  • 医学
Access the American College of Cardiology’s clinical guideline recommendations and use interactive tools such as risk scores, dosing calculators, and algorithms through the ACC’s Guideline Clinical App. The App also includes features such as customizable bookmarks, note-taking, and emailable pdfs. ACC’s Guideline App is free to both members and nonmembers. This app is the ACC’s mobile home for clinical guideline content and tools for clinicians caring for patients with cardiovascular disease. Current guidelines in the App include: • Atrial Fibrillation (AF) • Cardiovascular Risk (CV Risk) • Coronary Artery Bypass Graft (CABG) • Cholesterol (Chol) • Device-Based Therapy (DBT) • Dual Antiplatelet Therapy Update (DAPT) • Heart Failure (HF) • High Blood Pressure (BP) • Hypertrophic Cardiomyopathy (HCM) • Lifestyle (Lstyle) • Non–ST-Elevation Acute Coronary Syndromes (NSTEMI) • Obesity • Percutaneous Coronary Intervention (PCI) • Peripheral Artery Disease (PAD) • Perioperative Management for Noncardiac Surgery (Periop) • Stable Ischemic Heart Disease (SIHD) • ST-Elevated Myocardial Infarction (STEMI) • Supraventricular Tachycardia (SVT) • Syncope • Valvular Heart Disease (VHD) • Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (VA/SCD) Stay tuned for ongoing updates, more guideline content, and tools. Send feedback to the ACC directly from the App Information page or post a review in the App Store. Help us find new and better ways to deliver guideline content to clinicians. The information, text, graphics, images, trademarks and other materials (collectively, “Content”) that may be contained in the Guidelines Mobile Application (“App”) is presented as an educational service intended for licensed health care professionals. While the Content in the App is about specific medical and health care issues, the Content is not a substitute for or replacement of personalized medical advice and is not intended to be used as the sole basis for making individualized medical or health-related decisions. The views and opinions expressed in the App are those of the contributing authors and editors and do not necessarily represent the views of the ACCF. The Content is not intended to present the only, or necessarily best, methods or procedures for the medical situations addressed, but rather is intended to represent an approach, view, statement or opinion. ACCF hereby expressly disclaims responsibility for any liability arising from or in connection with the application of the Content in the App by you.
ACC Guideline Clinical App

ACC Guideline Clinical App使用ランク

使用ランクは、28日間の現在のインストール数とアクティブユーザー数を計算するSimilarwebのアルゴリズムに基づいています。

業界別 ウェブサイトカテゴリーで
米国--
医学で
米国#842

デイリーアクティブユーザー数(DAU)

期間中のACC Guideline Clinical Appダウンロード数と毎日のアクティブユーザー数を表示して、ACC Guideline Clinical Appユーザーの使用パターンを分析。

ユーザー

期間中のACC Guideline Clinical Appダウンロード数と毎日のアクティブユーザー数を表示して、ACC Guideline Clinical Appユーザーの使用パターンを分析。

デイリーアクティブユーザーをロック解除
3月4月5月

ACC Guideline Clinical App時間の経過に伴う ランキングの統計

Similarwebの使用ランクとACC Guideline Clinical App向けGoogle Play ストアランク

使用率ランキング

ランキング

ACC Guideline Clinical Appの国別ランキング

メインカテゴリ ACC Guideline Clinical App で最もランクが高い郡


ユーザーの興味・関心とトップカテゴリー

ACC Guideline Clinical Appユーザーが使用するトップカテゴリーとアプリ

上位カテゴリー
親和性
カテゴリー内の上位アプリ
43%
MyEvaluations.com Mobile
PowerMic Mobile
Doximity - Medical Network
Epic Haiku
32%
Boards (ABIM & ABFM)
UWorld Medical Exam Prep
Duolingo: Language Lessons
7%
Pizza Hut - Delivery & Takeout
6%
Files by Google
Clock
Google

トップ競合他社と代替アプリ

同じストアから同じユーザーによって使用される可能性が高いアプリ。

Nice Healthcare

Nice Healthcare

Nice Healthcare

SuppCo: Supplement Scanner

SuppCo: Supplement Scanner

SuppCo

Saunders Comp Review NCLEX PN

Saunders Comp Review NCLEX PN

Skyscape Medpresso Inc

OpenEvidence

OpenEvidence

OpenEvidence

ACC Guideline Clinical App VS.

5月 3, 2026